Resistance to diet-induced obesity is associated with increased proopiomelanocortin mRNA and decreased neuropeptide Y mRNA in the hypothalamus

Brain Research

Volumn 851, Issue 1-2, 1999, Pages 198-203

  Bergen, Hugo T ^a   Mizuno, Tooru ^b   Taylor, Jason ^a   Mobbs, Charles V ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Diet induced obesity; High fat diet; Hypothalamus; Neuropeptide Y; Proopiomelanocortin

Indexed keywords

GLUCOSE; INSULIN; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; GENE EXPRESSION; HYPOTHALAMUS; IN SITU HYBRIDIZATION; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIETARY FATS; HYPOTHALAMUS; INSULIN; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; NEUROPEPTIDE Y; OBESITY; PRO-OPIOMELANOCORTIN; RNA, MESSENGER;

EID: 0033401863     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02186-1     Document Type: Article

References (24)

1. Bergen H.T., Mobbs C.V. Ventromedial hypothalamic lesions produced by gold thioglucose do not impair induction of NPY mRNA in the arcuate nucleus by fasting. Brain Res. 707:1996;266-271.
2. Black B.L., Croom J., Eisen E.J., Petro A.E., Edwards C.L., Surwit R.S. Differential effects of fat and sucrose on body composition in A/J and C57Bl/6 mice. Metabolism. 47:1998;1354-1359.
3. B.S. Brownlow, A. Petro, M.N. Feinglos, R.S. Surwit, The role of motor activity in diet-induced obesity in C57Bl/6J mice, Physiol. Behav. (1996), 37-41.
4. Clark J.T., Kalra P.S., Crowley W., Kalra S.P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 115:1984;427-429.
5. Erickson J.C., Holopeter G., Palmiter R.D. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science. 274:1996;1704-1707.
6. Flier J.S., Maratos-Flier E. Obesity and the hypothalamus: novel peptides for new pathways. Cell. 92:1998;437-440.
7. Hagan M.M., Rushing P.A., Schwartz M.W., Yagaloff K.A., Burn P., Woods S.C., Seeley R.J. Role of the CNS melanocortin system in the response to overfeeding. J. Neurosci. 19:1999;2362-2367.
8. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
9. Kesterson R., Huszar D., Lynch C., Simerly R., Cone R. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol. Endocrinol. 11:1997;630-637.
10. Krude H., Biebermann H., Luck W., Horn R., Brabant G., Grüters A. Severe early onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nature Genet. 19:1998;155-157.
11. Levin B.E., Dunnmeynell A.A. Dysregulation of arcuate nucleus preproneuropeptide Y mRNA in diet-induced obese rats. Am. J. Physiol. 272:1997;R1365-R1370.
12. Mizuno T.M., Bergen H.T., Funabashi T., Kleopoulos S.P., Zhong Y., Bauman W.A., Mobbs C.V. Obese gene expression: reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity. Proc. Natl. Acad. Sci. (USA). 93:1996;3434-3438.
13. Mizuno T., Kleopoulos S., Bergen H., Roberts J., Priest C., Mobbs C. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes. 47:1998;294-297.
14. Parekh P.I., Petro A.E., Tiller J.M., Feinglos M.N., Surwit R.S. Reversal of diet-induced obesity and diabetes in C57Bl/6J mice. Metabolism. 47:1998;1089-1096.
15. Sanacora G., Kershaw M., Finkelstein J.A., White J.D. Increased hypothalamic content of NPY mRNA in genetically obese Zucker rats and in its regulation by food deprivation. Endocrinology. 127:1990;730-737.
16. Schwartz M., Seeley R., Woods S., Weigle D., Campfield L., Burn P., Baskin D. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes. 46:1997;2119-2123.
17. Stanley B.G., Kyrkouli S.E., Lampert S., Leibowitz S.F. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides. 7:1986;1189-1192.
18. Surwit R.S., Feinglos M.N., Rodin J., Sutherland A., Petro A.E., Opara E.C., Kuhn C.M., Rebuffescrive M. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism. 44:1995;645-651.
19. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., Feinglos M.N. Diet-induced Type II diabetes in C57BL/6J mice. Diabetes. 37:1988;1163-1167.
20. Surwit R.S., Petro A.E., Parekh P., Collins S. Low plasma leptin in response to dietary fat in diabetes- and obesity-prone mice. Diabetes. 46:1997;1516-1520.
21. Surwit R.S., Seldin M.F., Kuhn C.M., Cochrane C., Feinglos M.N. Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes. 40:1991;82-87.
22. Thornton J., Cheung C., Clifton D., Steiner R. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology. 138:1997;5063-5066.
23. Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., Jeanrenaud B. Chronic intracerebroventricular neuropeptide Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology. 133:1993;1753-1758.
24. Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., Jeanrenaud B. Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes. 43:1994;764-769.